Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | G-CSF | 19.0 | 47 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | G-CSF | 16.0 | 37 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | G-CSF | 16.0 | 69 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | G-CSF | 16.0 | 67 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | G-CSF | 17.0 | 67 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | G-CSF | 19.0 | 47 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | G-CSF | 19.0 | 71 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | G-CSF | 17.0 | 57 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | G-CSF | 18.5 | 66 | ||||
RA1869 | 1 | G-CSF | 16.0 | 74 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | G-CSF | 16.0 | 59 | ||||
N2759 | 1 | G-CSF | 16.5 | 48 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | G-CSF | 16.0 | 45 | ||||
RA1931 | 1 | G-CSF | 18.0 | 69 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | G-CSF | 20.0 | 47 | ||||
N2586 | 1 | G-CSF | 19.0 | 45 | |||||||
0 | G-CSF | 24.5 | 40 | ||||||||
0 | G-CSF | 19.0 | 56 | ||||||||
0 | G-CSF | 24.0 | 60 | ||||||||
0 | G-CSF | 22.0 | 75 | ||||||||
0 | G-CSF | 22.5 | 56 | ||||||||
0 | G-CSF | 19.0 | 32 | ||||||||
RA2159 | 2 | G-CSF | 129.5 | 64 | |||||||
N2645 | 2 | G-CSF | 21.0 | 69 | |||||||
RA2708 | 2 | G-CSF | 25.0 | 62 |